Trading Signals: BMRN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Oct. 27, 2023)(Biomarin Pharmaceutical Inc)
| BMRN latest price $81.1900 (3.16%) ($78.7000 - $82.0000) on Tue. Mar. 18, 2014. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 0.71% (three month average) | | RSI | 50 | | Latest Price | $81.1900(3.16%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | BMRN advances 52% a day on average for past five trading days. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support BMRN advance at 0% a week (0% probability)
VT(40%) IGOV(6%) EMHY(5%) PCY(5%) XAR(4%) | | Factors Impacting BMRN price | BMRN will decline at least -0.355% in a week (0% probabilities).
GDXJ(-5%) UUP(-4%) XBI(-3%) QQQ(-3%) XHB(-2%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.355% (StdDev 0.71%) | | Hourly BBV | 0 () | | Intraday Trend | 2.7% | | | | | |
|
| 5 Day Moving Average | $47.45(71.11%) | | 10 Day Moving Average | $0(INF%) | | 20 Day Moving Average | $0(INF%) | | To recent high | 0% | | To recent low | 5% | | Market Cap | $14.707b | | | | | | |
BioMarin Pharmaceutical, Inc. is a biotechnology company, which develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its products include Aldurazyme, Brineura, Kuvan, Naglazyme, Palynziq and Vimizim. The company was founded by Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA. |